Cetrea is a Finalist for the 2011 Red Herring 100 Global Award

CetreaRed Herring announced that Cetrea A/S has been selected as a candidate for Red Herring's 2011 Top 100 Global award, a prestigious recognition honoring the year's most audacious and far reaching private technology companies and entrepreneurs from across the globe.

The Red Herring editorial team selected the companies demonstrating the most innovative technologies and business models originating from over 1000 companies from over 40 nations. These companies, representing past Red Herring Asia, Europe and North America awards, are judged on a range of qualitative and quantitative metrics, including but not limited to, technology innovation, financial performance, growth criterion, management's execution standards, potential globalization of the strategy and market share improvement.

"Technology companies are becoming the bright spot in the economic outlook based on their increasing role within macro-economic environments" stated Alex Vieux, Chairman of Red Herring. "2011 has confirmed the sector's vibrant activity and its resilience to widespread economic problems. An unprecedented number of entrepreneurs are attempting to jump ahead of the competition and aspire to make a difference. Breakthroughs obsolete each other faster than ever before. Cetrea A/S has performed exceptionally in its field and strongly deserves to be singled out as one of the Red Herring Global Finalists. At this stage, we are left with the daunting task to select the best qualified companies for the 2011 Top 100 Global Award."

Related news articles:

About Cetrea
Cetrea A/S develops software products for hospitals based on the latest research within Pervasive Healthcare and PoCCS (Perioperative Communication and Coordination System).

The development of the initial Cetrea product (Cetrea Surgical™) started back in 2003 as a research project at the Regional Hospital of Horsens in Region Central Denmark under the name iHospital. iHospital resultet in a new generation of solutions for clinicians which in its strategic focus and use is significantly different from traditional types of solutions. The clinicians' enthusiasm for this new solution and the wish to keep iHospital (Cetrea Surgical) in production resulted in the establishment of C3A Medical in 2006.

As part of the company's strategy for growth both in Denmark and internationally the company name was changed from C3A Medical A/S to Cetrea A/S in september 2008. At the same time Cetrea was registered as trademark for the company's existing and future product suite.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

Call for Papers: AI Applications in Biom…

JMIR Biomedical Engineering is inviting submissions for a new section titled "AI Applications in Biomedical Engineering." This themed section explores the integration of biomedical engineering and artificial intelligence (AI), focusing...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...